Pipeline
Pipeline
R&D Programs
Hongcheng Biopharma pipeline consists of in-house research and development programs and out-licensing programs.
Format Indication Discovery PCC Preclinical IND PI PII PIII NDA
1 Trispecific Ab Solid tumor
2 mAb Solid tumor
3 ADC TNBC
4 Prodrug Solid tumor
5 ADC Solid tumor
6 mAb SLE
© 2021 Hongcheng Medicine all rights reserved. 沪ICP备2021025641号-1